PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Institute of Public Health, Faculty of BioMedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.\', \'Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.\', \'Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'General Directorate of Health, Geneva, Switzerland.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciab495
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34043763
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all